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Consumpti on 
of Omega-3 Fatty Acid-Enriched Eggs 
and Serum Lipids in HUlnans 
Ji-Young Lee 
Nancy M. Lewis 
Sheila E. Scheideler 
Timothy P. Carr 
ABSTRACT. This study examined the effectiveness of consuming 
omega-3 fatty acid-enriched eggs (Omega Eggs) in increasing rotal di-
clary omcga-3 fatty acids. Also examined was the impact of OmegaE~gg 
consumption on serum lipids. Sixteen hypercholesterolemic men and 
women with baseline serum total cholesterol concentrations of 5. J 7-7.76 
mmoliL (200-300 mg/dL) followed the National Cholesterol Education 
Program Step I diet guidelines under the following conditions: (a) Step 1 
diet without eggs, (b) Step I diet plus 12 regular eggs per week, and 
(c) Step I diet plus 12 Omega Eggs per week. The study design was a re-
peated 3 X 3 Latin square so that each subject received each of the three 
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diet treatments. Consumption of Omega Eggs significantly increased 
omega-3 fatty aeid intake (1.18 g/day) compared to consumption ot reg-
ular eggs (0.71 g/day) or no eggs (0.81 g/day). The Omega Egg treatment 
did not significantly alter serum eholesterol or triacylglycerol concentra-
lion when all ] 6 subjects were included in the analysi~. However, three 
subjects showed a significant increase in serum total cholesterol coneen-
tration when consuming regular eggs relative to no eggs. When these 
"responders" consumed Omega Eggs, serum tolal cholesterol concentra-
tion did not increase, despite a 3-fold increase in cholesterol intake rela·· 
live to no egg treatment. These data suggest that Omega Eggs (12/week) 
can be included in the National Cholesterol Education Program Step I 
diet without increased serum total cholesterol or triacylglycerol concen-
tration. In this way, [he nutritional benefits of eggs could be realized 
without the detrimental effects of increased cholesterol intake. fAr/iele 
copies {{vailable for a fee from The Hmvorth Documem J)elivery Service: 
J ·800·H,1 WORTH E·mail address: <getinji-!@haw(Jr/hpress.coll1> Wehsite: 
<hflp.//www.HaworIIiPress.com> © 2003 by The Haworrh Press, fllc. All rights 
reserved.} 
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INTRODUCTION 
Consumption of fish rich in omcga-3 PUFA in the United States is 
approximately One serving per week,) while the dietary recommenda-
tion i.s one to l\vO fish meals per wcck2 Because the intake of fish is gen-
erally low. finding altemative sources of omega-3 PUFA is necessary to 
increase the omega-3 PUFA consumption in the United States and other 
countdes. 
Eggs have been studied as an alternative food source of ornega-3 
PUFA because they can be produced with an altered fatty acid composi-
tion, depending on the hens' feed.HIt is reported that inclusion of vari-
ellis sources of orncga-3 PUFA in hens' feed resulted in up to 220 mg of 
ornega-3 PUPA per egg yolk, equivalent to the amount of omega-3 
PUPA in a 100 g serving of lean fish. 'i Marshall et a1. 6 repOlted that 
omega-3 fatty acid-enriched eggs could be incorporated as an omega-3 
PlJFA source into the diet of health-conscious consumers. 
Epidemiological studies in Greenland Eskimos led to the hypothesis 
that fish oil rich in omega·3 polyunsaturated fatty acids (PUFA) re-
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duces the risk of atherosclerosis.7-9 Research has shown that dietary 
omega-3 PUFA reduce atherosclerosis development, at least in part, by 
regulating serum cholesterol and triacylglycerol concentration W 
A few studies have been conducted to investigate the effects of 
omega-3 fatty acid-enriched eggs on plasma lipid concentration. The 
con:;,umption of four omega-3 fatty acid-enriched eggs per day resulted 
in lowered plasma triacylglycerol concentration and systolic and dia-
stolic blood pressure, although plasma cholesterol concentration was 
not affected. I 1 Ferrier et a1. 12 reponed that incorporation offour a-linolenic 
acid-enriched eggs per day to the typical diets of nOlmolipidemics had 
no significant effect on SellJITI cholesterol or triacylglycerol concentra-
tion. In contrast, Jiang and Sim 13 showed that rats consuming omega-3 
PUFA-enriched egg yolks reduce both plasma and liver cholesterol 
concentration. More research is needed to further delineate the role of 
dietary orncga-3 fatty acid-enriched eggs in regulating plasma lipid 
conccntrations. Therefore, the present study was conducted to deter-
mine the serum lipid response in hypercholesterolcrnic humans con-
suming eggs enriched in omega-3 fatty acids. 
MATERIALS AND METHODS 
Slll~iects 
Subjects represent a subset of individuals who participated in a larger 
study previously pubJished14 Thc sixteen subjects selectcd for this 
study are those that successfully completed all three treatment periods 
described below. Volunteers were recruited through advertisements 
and f1yers directed toward individuals whose serum tOlal cholesterol 
levels were 5.17-7.76 111M (200-300 mg/dL) and considered hyper-
cholesterolemic. They were screened for general good health and will-
ingness to comply with the procedures of the study. People who had 
health risks or factors affecting serum cholesterollevcls were excluded. 
The exclusion critelia were: Pregnant or lactating women wishing to 
conceive over the period of study; tobacco users; alcohol users more 
than two drinks per day; regular users of prescription dllJgS for lowering 
cholesterol; regular blood donors and not willing to forgo this activity 
during the study; subjects allergic to eggs or egg products; subjects 
planning a weight-loss diet; subjects who experienced an addiction to 
drugs or alcohol within the last two years; subjects with high blood 
prcssurc; and subjects with a body mass index t,'Teatcr than 32.5 kg/m2 
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Diets and Experimental Design 
The dietary protocol was based on the National Cholesterol Educa-
tion Program (NCEP) Step T diet which suggests 3()% of total calories 
from fat, 10% total calories from saturated fat, and less than 300 mg/day 
of dietary cholesterol. J 5 Each subject was instructed to keep this diet re-
gime throughout the study. Diet records were kept for three non-consec-
utive days during the last two weeks of each six-week treatment period 
and were analyzed using the Food Processor Plus computer program, 
Version 5.0 (ESHA Research, Salem, OR). Table I shows the diet COIll-
positions during each treatment period. 
Three diet treatments were used in this study: (l) NCEP Step I diet 
and no egg, (2) NCEP Step I diet plus 12 regular eggs per week, and 
(3) NCEP Step I diet plus 12 omega-3 fatty acid-enriched eggs per 
week. The study design was a repeated 3 X 3 Latin square such that 
each subject received each of the three diet treatments. After a two-
week baseline period WId six week-stabilization period for the Step I 
diet, diet treatments were randomly assigned to subjects in a manner 
consistent with the Latin square protocol. Each diet treatment was con-
ducted for six weeks, with six-week washout periods between treat-
ments to minimize possible carryover effects. 
TABLE 1. Diet composition during treatment penods 
Treatrnent 
No Egg Regular Egg Omega Egg 
Total Energy, Jlday 7.47 ± 0,45 7,53±0.41 7431: 040 
Total Fat, % energy 25.2 ± 1.5 26.3 1.6 25.6:1: 1,6 
SFA, % energy 7,(;9 i: 0,61 8,58:! 0.64 7,85:t 0.47 
MlIFA, % energy 8.67 t.0.60 9.86 ± 069 9.40 t 0.65 
PlIFA, % energy 5.68t 0.53 5.22 ± 0.37 556 ± 0.44 
Omoga-3 FA, g/day 0811:0.148 0.71 ± 0.08 a 1.18 ±0.12 b 
Ornega-6 FA. glday 7.38 ± 0.92 6.96": 0.56 7.41±0.70 
Omega-6/omega-3 FA ratio 10.5 ± 0.9 b 10.7 ± 0.8 0 7.0i:0.8 " 
Cholesterol, mg/day 157±178 475t29 b 477:! 24 b 
VaitJes reprOsflnt mean -.~ SEM (n:::: 16 for each treatment). Va\ufls within the same row having different superscripts 
are srgni1icantly different (P < 0,05), using one~way repeated meaSures ANOVA and Fisher's multiple comparison 
test SFA, saturated fatty acids; MUFA, monounsaturated tatty acids; PUFA. pOlyunsaturated larty acids. 
IRe all/. 7 
The eggs used in this study were produced by the Dcpm1ment of Ani-
mal Science at the University of Nebraska-Lincoln. Regular eggs were 
produced by feeding hens a standard diet. Omega-3 fatty acid-enriched 
eggs (Omega Eggs) were produced utilizing a patented feeding formula 
and management program. 16 
Plasma and LDL Analysis 
Blood samples were taken after 12 hour fasting at the fourth week of 
each diet. Hed blood cells were removed and an aliquot of selllm was 
frozen at - 70°C. Selllm was analyzed within 24 hours for total choles-
terol, high density lipoprotein (HDL) cholesterol, total triacylgJycerol 
concentration according to NCEP guidelines. 17 Serum low density li-
poprotein (LDL) cholesterol concentration was calculated using the 
Friedewald equation. IR 
Selllm lipoprotcins wcre separated into fTaclions containing LDL 
and HDL by gel filtration chromatography using 4IJo agarose (BioGel A 
15m, 200 to 400 mesh, BioRad, Tnc., Hercules, CA) as described by 
Rudel et al. 19 The composition of serum LDL was determined by quan-
tifying the chemical components ofLDL particles (i.e., triacylglycerol, 
cho1csteryl ester, free cholesterol, phospholipid, and apolipoprotein 
B-lOO) as previously described 20 Briefly, serum LDL total cholesterol 
and triacylgJycero] concentration was measured enzymatically using 
commercially available reagents (Boehringer Mannheim, Indianapolis, 
IN). Unesterified (free) cholesterol was also measured enzymatically 
(Wako Chemicals USA, Inc., Richmond, VA). Esterified cholesterol 
was determined as the difference between total and free cholesterol. 
LDL phospholipids were estimated by measuring inorganic phosphorus 
using the method of Monison21 Apolipoprolein B-1 00 was measured 
hy immllnoturbidimetric assay (Sigma Chemical Co., St. Louis, MO). 
LDL particle diameter was calculaled according to the equation of Van 
Heek and Zilversmit. 22 
Statistical Analyses 
Statistical comparison among treatment groups was determined by 
repeated measures one-way anaJysis of variance and Fisher's least sig-
nificant difference test using Sigl11aStat (SPSS Science, Chicago, IL). 
Trcatmcnt differences were considered significant at the P < 0.05 level. 
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RESULTS 
Diet compositions from the analysis of diet records are shown in Ta-
ble ] . Dietary intake was similar dm-jng each treatment period with re-
gard to daily total energy intake and percent of energy from total fat, 
saturated (SF A ), monounsaturated (MUFA), and polyunsaturated (PUF A) 
fatty acids. The total daily intake of omega-3 fatty acids was signifi-
cantly higher and the omega-6/omega-3 ratio was significantly lower 
during Omega Egg treatment. Consumption of both Regular Eggs and 
Omcga Eggs resulted in higher cholesterol intake (P < 0.05). 
Serum lipid concentrations are shown in Table 2. No significant 
treatment differences were detected in serum total, LDL, or HDL cho-
lesterol or serum triacylglycerol. The chemical composition of serum 
LDL was also analyzed Cfable 3). No significant treatment differences 
were detected in the chemical composition of LDL expressed as the 
number of lipid molecules per LDL particle. There was a tendency of 
LDL molecular weight to be higher in the Regular Egg treatment, al-
though this trend did not reach statistical significance. 
Among the J 6 subjects there were three indi viduals whose serum to-
tal cholesterol concentration significantly increased during Regular 
Egg treatment compared to No Egg treatment Crable 4). Omega Egg 
treatment in these "cholesterol responders" prevented the increase in 
serum total cho1esteIOI concentration, which was significantly lower 
than Regular Egg treatment and similar to No Egg treatment. A similar 
trend was observed in serum LDL cholesterol and triacylglycerol con .. 
centration, but these ditlerences did not reach statistical significance. 
TABLE 2. Serum lipid concentrations 
No 
Total Cholesterol 5.94" 0.20 5.96 cL 0.20 6.05:t 0.20 
LDL C!lOlesterol 3.84±0.19 3.80 ± 0.21 3.95 ± 0.20 
HDL Cholesterol 1.30 ± 0.08 1.37 ± 0.10 1.34 ± 0.08 
Triacylglyceroi 1.75 ± 0.26 1.72 ± 0.26 1.66 ± 0.26 
Values represent mean ± SEM (n =- 16 for each treatment). No significant differences were detected among trea1-
ment groups, using one~way mpeated measures ANOVA. 
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TABLE 3. Serum LDL lipid composition, molecular weight, and particle diam-
eter 
... --~ ... ---.----.-.-.. -
Treatment 
No Egg Regular Egg Omega Egg 
Cnoles!eryl Ester, molecules/particle 2202 ± 52 2240 ± 92 2166± 132 
Triacylglycerol, molecules/particle 736 ± 53 822 ± 114 698 ± 47 
Free Cholesterol, molecules/particle 547:2: 41 575 ± 44 569 ± 50 
Phospl,olipid, molecules/particle 1334 ± 47 1433:1: 80 1339 t.57 
Molecular Weight, 9/)Jmo/e1 3.84 ± 0.07 4.03:1: 0.19 3.80 0.17 
LDL Diameter. angstroms 225± 5 223.'.1,7 216 ± 5 
Values represent mann ± SEM (n = 16 for oRch treatment). No significant differences were dotected among treat-
ment using one-v.,ray repeated measures ANOVA 
I relors to tho mas,; (grams) of LDL lipid and 8-100 constituents pel 01 
molecul.ar weight values were used to LOt. MW: cholesteryl 650; 
387; phospholipid, 775, and apotipoprolein 8-100, 513,000. 
TABLE 4. Serum lipid concentration in responders and nonresponders 
Responders (n = 3) Nonresponders (n = 13) 
No Egg Reqular Egg Omega Egg No Egg Regular Egg Omega Egg 
.... _._ ........ _----.. . ... _-....... _-_..... ------
mmalll 
T olal Cholesterol 5.84 :t 0.69 " 6.35.l 0.56 b 5.97 ± 0.6:3 a 5.96,t: 0.20 5.87 :':. 0.21 6.06 ± 0.22 
LDt. Cholesterol 4.04 :t 0.65 4.26 :1: 048 4.03:t,O.59 3.79:t,O.20 3.70:L 0.24 3.93 J'. 0.22 
HDL Cholesterol 1.15 -1, 0.'17 1.24 0.24 129t 0.15 1.33:t 0.09 1.40.'.0.11 1.35.;: 0.10 
Triacylglycerol 143 ± 0.38 1.87 ± 0.58 1.44 ± 045 1.83 ± 0.31 1.69 ± 0.30 1.72 ±. 0.31 
... ~-.. ----------
Vaiues represent mean ± SEM. Values wi\hin !he same row having different supersCripts are slgnilicanUy differef\t 
(P < 0.05), using o-re-way repea~ecJ measures ANOVA and Fisher's multiple comparison \est 
DISCUSSION 
This study was conducted to determine whether total omega-3 fatty 
acid intake could be increased in a habitual diet by consuming eggs en-
riched in omega-3 fatty acids (Omega Eggs). Also examined was the 
impact of consuming Omega Eggs on semrn lipid concentration and 
LDL chemical composition. The results show that addition of Omega 
Eggs to the subjects' diets significantly increased total orncga-3 fatty 
acid intake compared to No Egg and Regular Egg treatment. Although 
omega-3 fatty acid intake increased about 400-500 mg/day by consum-
ing Omega Eggs, this dietary level had limited impact on serum lipids, 
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Dietary linolenic acid (CI8:3) can be converted to docosahexaenoic 
acid (C22:6) in the body, which is physiologically essential for normal 
function of nervous tissue membranes. However, the enzymes involved 
in this conversion are common to the pathway for the elongation and 
dcsaturation of linoleic acid (C18:2), and competition with omega-6 
fatty acids will reduce the amount of C18:3 converted to C22:6.23 
Hence, dietary recommendations in Canada include an omega-6 to 
omega-3 fatty acid ratio as low as 4: \ and not higher than 10: }24 The 
omcga-6 to omcga-3 fatty acid ratio in the No Egg and Regular Egg 
treatments were slightly higher than 10: 1, which is a simi lar ratio re-
ported by Raper et aps The omega-6 to omega-3 fatty acid ratio in the 
Omega Egg treatment was 7: I. This is an important consideration be-
cause both long-chain omega-6 and omega-3 fatty acids are used for 
synthesis of specific eicosanoids as well as serving a functional role in 
cellular membrane phospholipids. 
Serum lipid concentrations were relatively unchanged by the addi-
tion of Regular Eggs or Omega Eggs to the diet Cfable 2). In a simi lar 
study, Ferrier et al. 12 also found no significant differences in plasma to-
tal or HDL cholesterol concentration in subjects consuming either four 
regular eggs or four omega-3 fatty acid-enriched eggs per day. In con-
trast, Oh et al. ll reported that plasma total cholesterol concentration was 
significantly increased by consumption of regular eggs but unchanged 
in subjects fed four omega-3 fatty acid-enriched eggs per day. Because 
of the wide variation in serum lipid response seen in the human popula-
tion, it is possible that our sample size was too small to detect a choles-
terol-lowering effect of omega-3 fatty acids at the levels cunsumed in 
our study. There were, however, three subjects whose serum total cho-
lesterol concentration significantly increased dW'ing the Regular Egg 
treatment (Table 4). The proportion of "cholesterol responders" to di-
etary cbolesterol in the present study (19%) is consistent with the pro-
portion found in the general popUlation, which is estimated to be 
15-20%26 There is now substantial evidence that while dietary choles-
terol has little effect on serum cholesterol concentration in Lhe general 
population,27,28 there exists a high degree of variability in the response 
of individuals to dietary cho\csterol. 26 This conclusion is suppurted by 
the present data, although one should be cautious ahout overemphasiz-
ing the results of only three subjects. 
Dietary omega-3 fatty acids have been reported to lower serum 
triaeylglycerol concentrations. 29-32 Although Omega Egg consumption 
significantly increased omega-3 fatty acid intake, no significant differ-
ences in serum triacylglycefol concentration was observed among treat-
Lee et at. !l 
ments. In the three responders, Omega Egg consumption appeared to 
prevent the tendency for serum triacylglycerol concentration to increase 
when Regular Eggs were consumed. In a previous study, a fish oil diel 
containing 24 g/day of omega-3 fatty acids significantly lowered plasma 
triacylglycerol concentration Lower doses of fish oil (2-8 g/day of 
omega-3 fatty acids) were also effective at reducing plasma triacyl-
glycerol eoncentration 34 ,3S In the present study, the mean omega-3 
fany acid intake was 1 18 g/day during Omega Egg treatment. While 
this level of intake was significantly higher than No Egg or Regular Egg 
treatment, it was apparently too low to elicit a significant change in se-
rum lriacylglycerol concentration. 
Another objective of this study was (0 measure the compositional 
changes in serum LDL particles as influenced by dietary omega-3 fatty 
acids. No significant compositional changes were detected in the major 
lipid components of LDL Our results are consistent with S0rensen et 
a]36 who reported no effect of omega-3 fatty acid consumption (- I 
g/day) on LDL chemical composition or size. Grealer dietary intake of 
omega-3 fatty acids may be required to elicit changes in LDL composi-
tion or to enrich LDL lipids with omega-3 fatty acids. 
CONCLUSIONS 
The inclusion of Omega Eggs (12/weck) to the NCEP Step I uiet sig-
nificantly increased the omega-3 fatty acid content of the diet approxi-
mately 400-500 mg/day. Omega Egg consumption also appeared to 
prevent an increase in serum total cholesterol concentration in three in-
dividuals who appeared to he "responders" to dietary cholesterol. These 
data suggest a therapeutic use of Omega Eggs in managing serum cho-
lesterol in l11dividuals who are sensitive to dietaty cholesterol. In this 
way, tbe nutritional benefits of eggs could be realized without the detri-
mental effects of increased cholesterol intake. 
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